Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.55M Buy
4,300
+1,800
+72% +$2.87M 0.07% 192
2026
Q1
$3.3M Buy
2,500
+2,000
+400% +$2.74M 0.02% 336
2025
Q4
$535K Hold
500
– – ﹤0.01% 701
2025
Q3
$484K Hold
500
– – ﹤0.01% 650
2025
Q2
$401K Buy
+500
New +$359K 0.01% 1068
2025
Q1
– Sell
-1,400
Closed -$970K – 1542
2024
Q4
$970K Hold
1,400
– – 0.02% 536
2024
Q3
$1.17M Buy
1,400
+400
+40% +$358K 0.02% 756
2024
Q2
$1.02M Hold
1,000
– – 0.02% 763
2024
Q1
$970K Buy
+1,000
New +$887K 0.02% 680
2021
Q4
– Sell
-300
Closed -$224K – 1194
2021
Q3
$224K Sell
300
-1,200
-80% -$943K 0.01% 893
2021
Q2
$1.04M Sell
1,500
-12,700
-89% -$8.38M 0.02% 555
2021
Q1
$8.77M Buy
+14,200
New +$7.88M 0.33% 51

Other funds holding ASML

Centiva Capital's ASML Position: Q2 2026 in Review

Centiva Capital reduced its ASML (ASML) stake by 63% in Q2 2026, selling an estimated $4.34M and leaving 1,628 shares worth $3.24M. The position accounts for 0.03% of the portfolio, ranked #342.

Centiva Capital first reported a position in ASML in Q4 2018 and has held it in 15 quarters since. The position peaked at $5.75M in Q1 2026. 2,515 funds tracked by Wall St. Rank hold ASML as of Q2 2026.

  • Centiva Capital held 1,628 shares of ASML worth $3.24M as of Q2 2026.
  • Centiva Capital sold 2,729 ASML shares in Q2 2026, an estimated $4.34M.
  • ASML made up 0.03% of Centiva Capital's portfolio in Q2 2026, its #342 holding.
  • Centiva Capital first reported a position in ASML in Q4 2018 and has held it in 15 quarters since.
  • Centiva Capital's ASML position peaked at $5.75M in Q1 2026.
  • 2,515 funds tracked by Wall St. Rank held ASML as of Q2 2026.

Based on Centiva Capital's 13F filing for Q2 2026, filed 13 Aug 2026.